ELECTRONIC POSTER - ismrm
ELECTRONIC POSTER - ismrm
ELECTRONIC POSTER - ismrm
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Tuesday 13:30-15:30 Computer 62<br />
13:30 4092. Background Correction of Phase-Based Arterial Input Functions<br />
Anders Garpebring 1 , Patrik Brynolfsson 1 , Ronnie Wirestam 2 , Nils Östlund 3 , Mikael<br />
Karlsson 1<br />
1 Radiation Sciences, Umeå University, Umeå, Sweden; 2 Medical Radiation Physics, Lund University, Lund,<br />
Sweden; 3 Biomedical Engineering and Informatics, Umeå University Hospital, Umeå, Sweden<br />
Phase sensitive MRI has shown great potential for quantification of the Arterial Input Function (AIF). However, motion induced phase<br />
artefacts are problematic for in-vivo measurements and must be compensated for. The purpose of this study was to compare three<br />
different background ROI selection procedures for compensation of phase errors. Results showed that efficient correction of motion<br />
induced phase shifts requires a background ROI placed close to the vessel from which the AIF is sampled. Some further improvement<br />
can also be achieved by tracking and compensating for any in-plane motion of the vessel.<br />
14:00 4093. Preliminary Results with 3D DCE-MRI Curve Pattern Analysis of Treatment<br />
Response in Osteosarcoma<br />
Junyu Guo 1 , Qing Ji 1 , Mary E. McCarville 1 , Najat C. Daw 2 , Wilburn E. Reddick 1<br />
1 Radiological Science, St Jude Children's Research Hospital, Memphis, TN, United States; 2 Department of<br />
Oncology, St Jude Children's Research Hospital, Memphis, TN, United States<br />
A new osteosarcoma treatment protocol in our Institute includes a multiagent chemotherapy with an anti-angiogenic agent<br />
(bevacizumab). Serial DCE-MRI was performed at six different time points during neoadjuvant therapy, and a recently developed<br />
DCE-MRI data analysis method, the CPA method, was used to process the data and assess treatment response in the first eight<br />
patients. According to our preliminary results, it is feasible to assess the tumor treatment response to neoadjuvant therapy using the<br />
CPA method in DCE-MRI. Further investigation of this CPA method on a larger cohort of patients will be performed.<br />
14:30 4094. The Effect of Blood Inflow and B 1 -Field Inhomogeneity on Measurement of the AIF<br />
in<br />
Axial 3-D SPGR DCE-MRI<br />
Caleb Roberts 1,2 , Ross A. Little 1,2 , Yvonne Watson 1,2 , Sha Zhao 1,2 , David L. Buckley 3 ,<br />
Geoff J M Parker 1,2<br />
1 Imaging Science and Biomedical Engineering, The University of Manchester, Manchester, United Kingdom,<br />
United Kingdom; 2 The Biomedical Imaging Institute, The University of Manchester, Manchester, Greater<br />
Manchester, United Kingdom; 3 Division of Medical Physics, University of Leeds, Leeds, United Kingdom<br />
A major potential confound in axial 3-D dynamic contrast-enhanced MRI (DCE-MRI) studies is the blood inflow effect and therefore<br />
the choice of slice location for arterial input function (AIF) measurement within the imaging volume must be considered carefully.<br />
Using a combination of computer simulations, flow phantom and in vivo studies we describe and understand the effect of blood inflow<br />
on the measurement of the AIF. We demonstrate that reliable AIFs are achievable in 3-D DCE-MRI but the use of inflow affected<br />
AIFs in tracer kinetic modeling result in large errors in tissue microvascular parameters.<br />
15:00 4095. Introducing New DCE Parametric Maps to Quantify Vascular Changes Induced by<br />
the Anti-Angiogenic<br />
Drug Sunitinib<br />
Areen Al.Bashir 1,2 , Gilda Hillman 3 , Meng Li 2 , Yashwanth Katkur 2 , E. Mark Haacke 1,2<br />
1 Department of Biomedical Engineeringt, Wayne State University, Detroit, MI, United States; 2 Department of<br />
Radiology, Wayne State University, Detroit, MI, United States; 3 Department of Radiation Oncology, Wayne<br />
State University<br />
DCE-MRI has been routinely used to quantify the effectiveness of new anti-angiogenic drugs on the tumor vasculature using Gd-<br />
DTPA as a contrast agent. However, this quantification is not easy. DCE has a lot of parameters that make it a very complex<br />
technique, such as finding AIF and choosing the pharmacokinetic model. Hence, in this study, we introduced the new DCE parametric<br />
maps which was calculated from Gd concentration, C(t), data. Regional analysis were preformed on 4 groups of mice treated with<br />
different dose of the anti-angiogenic drug, sunitinib, and the results compared. Our results demonstrate that DCE parametric maps<br />
have the potential to quantify the effect of new anti-angiogenic drugs on tumor and normal tissues. These findings were confirmed<br />
with histological observations.